Trident Texofab

{
  "main_header": {
    "sid": 1002850,
    "name": "Trident Texofab",
    "stock_name": "Trident Texofab",
    "full_name": "Trident Texofab Ltd",
    "name_url": "stocks-analysis/trident-texofab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "188.20",
    "chg": -9.9,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "198.10",
    "mcapval": "282.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540726,
    "symbol": "",
    "ind_name": "Garments & Apparels",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE071Y01013",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.44 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/trident-texofab-1002850-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Texofab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-ltd-is-rated-sell-3805211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentTexofabL_mojoScore_3805211.png",
        "date": "2026-01-27 10:10:49",
        "description": "Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Trident Texofab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-ltd-is-rated-sell-3781271",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TridentTexofabL_mojoScore_3781271.png",
        "date": "2026-01-05 10:15:12",
        "description": "Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Trident Texofab Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-texofab-ltd-fallingrising-3771751",
        "imagepath": "",
        "date": "2025-12-27 00:48:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Trident Texofab Ltd has been experiencing a sustained decline over the past week, with the stock losing 7.79% in value. This contrasts sharply with the Sensex, which recorded a marginal gain of 0.13% during the same period. The stock’s underperformance is further highlighted by its 1-month return of -26.54%, significantly worse than the Sensex’s modest decline of 0.66%. Despite this short-term weakness, the stock has delivered impressive long-term returns, with a year-to-date gain of 48.51% and a five-year return exceeding 768%, far outpacing the benchmark’s 81.04% over the same period.</p>\n<p><strong>Intraday Trading and Technical Indicators</strong></p>\n<p>On 26-Dec, the stock touched an intraday low of ₹247.25, marking a 3.7% dr..."
      },
      {
        "title": "Trident Texofab Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-ltd-is-rated-sell-3769027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentTexofabL_mojoScore_3769027.png",
        "date": "2025-12-25 12:58:29",
        "description": "Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Trident Texofab Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-texofab-downgraded-to-sell-by-marketsmojo-amid-valuation-and-quality-concerns-3750550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentTexofab_mojoScore_3750550.png",
        "date": "2025-12-08 10:10:51",
        "description": "Trident Texofab, a microcap player in the Garments & Apparels sector, has undergone a revision in its market evaluation reflecting a more cautious analytical perspective. This shift follows a detailed review of the company’s financial trends, valuation, quality metrics, and technical outlook, highlighting a complex investment profile despite notable recent returns."
      },
      {
        "title": "Is Trident Texofab overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-trident-texofab-overvalued-or-undervalued-3747854",
        "imagepath": "",
        "date": "2025-12-05 08:41:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Elevated Pricing</strong></p>\n<p>As of early December 2025, Trident Texofab’s valuation grade moved from expensive to very expensive. The company’s price-to-earnings (PE) ratio stands at an exceptionally high 171.99, signalling that investors are paying a substantial premium for each unit of earnings. This is further emphasised by a price-to-book (P/B) ratio of 8.95, which is well above typical industry averages, suggesting that the stock price is significantly higher than the company’s net asset value.</p>\n<p>Enterprise value multiples also reflect this elevated pricing. The EV to EBIT ratio is 82.13, and EV to EBITDA is 65.76, both indicating that the market values the company at many times its operating profits. The PEG ratio, which adjusts the PE ratio for earn..."
      },
      {
        "title": "Is Trident Texofab technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-trident-texofab-technically-bullish-or-bearish-3745688",
        "imagepath": "",
        "date": "2025-12-04 08:47:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Technical Position</strong></p>\n<p>As of 3 December 2025, Trident Texofab’s technical trend has shifted from bullish to mildly bullish. This subtle change indicates that while the stock retains positive momentum, the intensity of buying interest has moderated. The current market price stands at ₹336.55, slightly below the previous close of ₹343.00, and well off its 52-week high of ₹379.00, yet comfortably above the 52-week low of ₹122.90. Intraday trading on the latest session saw a high of ₹347.50 and a low of ₹336.55, reflecting some volatility but no decisive directional breakout.</p>\n<p><strong>Mixed Signals from Key Technical Indicators</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD) reveals a divergence in timeframe perspectives. The weekl..."
      },
      {
        "title": "Trident Texofab Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-texofab-technical-momentum-shifts-amid-mixed-indicator-signals-3745517",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentTexofab_technicaldot_3745517.png",
        "date": "2025-12-04 08:11:53",
        "description": "Trident Texofab, a key player in the Garments & Apparels sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition in price trends and technical indicators, signalling a nuanced outlook for investors amid fluctuating market conditions."
      },
      {
        "title": "How has been the historical performance of Trident Texofab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-trident-texofab-3744774",
        "imagepath": "",
        "date": "2025-12-03 22:55:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Trends</strong></p>\n<p>Examining the company's net sales from March 2019 through March 2025 reveals a notable increase from ₹86.90 crores in 2019 to ₹122.06 crores in 2025. Despite some volatility, including a dip in 2021 to ₹49.93 crores, the overall trend indicates recovery and expansion. Total operating income mirrors this pattern, with no other operating income reported during this period.</p>\n<p>Operating profit before depreciation, interest, and tax (PBDIT) excluding other income showed a rise from ₹2.40 crores in 2019 to ₹5.48 crores in 2025, peaking at ₹6.31 crores in 2023. When factoring in other income, operating profit improved further, reaching ₹8.78 crores in 2025. However, interest expenses have also increased, from ₹0.86 crores in 2019 to ₹4.55 crores in 202..."
      }
    ],
    "total": 265,
    "sid": "1002850",
    "stock_news_url": "https://www.marketsmojo.com/news/trident-texofab-1002850"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 as received from KFin Technologies Limited- Companys Registrar and Share Transfer Agent for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Dec-2025",
      "details": "Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from January 01 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter and Nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "15-Nov-2025",
      "details": "Earnings Presentation for the quarter and Half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Trident Texofab Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Jul 19",
          "dt": "2019-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Trident Texofab Ltd has announced <strong>14:10</strong> bonus issue, ex-date: 11 Aug 20",
          "dt": "2020-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Texofab Ltd is Rated Sell

2026-01-27 10:10:49

Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 January 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Trident Texofab Ltd is Rated Sell

2026-01-05 10:15:12

Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Trident Texofab Ltd falling/rising?

2025-12-27 00:48:30

Recent Price Movement and Market Performance

Trident Texofab Ltd has been experiencing a sustained decline over the past week, with the stock losing 7.79% in value. This contrasts sharply with the Sensex, which recorded a marginal gain of 0.13% during the same period. The stock’s underperformance is further highlighted by its 1-month return of -26.54%, significantly worse than the Sensex’s modest decline of 0.66%. Despite this short-term weakness, the stock has delivered impressive long-term returns, with a year-to-date gain of 48.51% and a five-year return exceeding 768%, far outpacing the benchmark’s 81.04% over the same period.

Intraday Trading and Technical Indicators

On 26-Dec, the stock touched an intraday low of ₹247.25, marking a 3.7% dr...

Read full news article

Trident Texofab Ltd is Rated Sell

2025-12-25 12:58:29

Trident Texofab Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Read full news article

Trident Texofab Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-08 10:10:51

Trident Texofab, a microcap player in the Garments & Apparels sector, has undergone a revision in its market evaluation reflecting a more cautious analytical perspective. This shift follows a detailed review of the company’s financial trends, valuation, quality metrics, and technical outlook, highlighting a complex investment profile despite notable recent returns.

Read full news article

Is Trident Texofab overvalued or undervalued?

2025-12-05 08:41:06

Valuation Metrics Indicate Elevated Pricing

As of early December 2025, Trident Texofab’s valuation grade moved from expensive to very expensive. The company’s price-to-earnings (PE) ratio stands at an exceptionally high 171.99, signalling that investors are paying a substantial premium for each unit of earnings. This is further emphasised by a price-to-book (P/B) ratio of 8.95, which is well above typical industry averages, suggesting that the stock price is significantly higher than the company’s net asset value.

Enterprise value multiples also reflect this elevated pricing. The EV to EBIT ratio is 82.13, and EV to EBITDA is 65.76, both indicating that the market values the company at many times its operating profits. The PEG ratio, which adjusts the PE ratio for earn...

Read full news article

Is Trident Texofab technically bullish or bearish?

2025-12-04 08:47:15

Overview of Current Technical Position

As of 3 December 2025, Trident Texofab’s technical trend has shifted from bullish to mildly bullish. This subtle change indicates that while the stock retains positive momentum, the intensity of buying interest has moderated. The current market price stands at ₹336.55, slightly below the previous close of ₹343.00, and well off its 52-week high of ₹379.00, yet comfortably above the 52-week low of ₹122.90. Intraday trading on the latest session saw a high of ₹347.50 and a low of ₹336.55, reflecting some volatility but no decisive directional breakout.

Mixed Signals from Key Technical Indicators

Examining the Moving Average Convergence Divergence (MACD) reveals a divergence in timeframe perspectives. The weekl...

Read full news article

Trident Texofab Technical Momentum Shifts Amid Mixed Market Signals

2025-12-04 08:11:53

Trident Texofab, a key player in the Garments & Apparels sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of market forces. Recent evaluation adjustments reveal a transition in price trends and technical indicators, signalling a nuanced outlook for investors amid fluctuating market conditions.

Read full news article

How has been the historical performance of Trident Texofab?

2025-12-03 22:55:37

Revenue and Profit Trends

Examining the company's net sales from March 2019 through March 2025 reveals a notable increase from ₹86.90 crores in 2019 to ₹122.06 crores in 2025. Despite some volatility, including a dip in 2021 to ₹49.93 crores, the overall trend indicates recovery and expansion. Total operating income mirrors this pattern, with no other operating income reported during this period.

Operating profit before depreciation, interest, and tax (PBDIT) excluding other income showed a rise from ₹2.40 crores in 2019 to ₹5.48 crores in 2025, peaking at ₹6.31 crores in 2023. When factoring in other income, operating profit improved further, reaching ₹8.78 crores in 2025. However, interest expenses have also increased, from ₹0.86 crores in 2019 to ₹4.55 crores in 202...

Read full news article

View All News